Conference Coverage: EHA 2023 – Focus on Leukemia and Myelodysplastic Syndrome (MDS) (Global)

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding leukemia

June 19, 2023

Faculty Chair

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX, USA

Faculty Members

Tapan M. Kadia, MD
MD Anderson Cancer Center, Houston, TX, USA

Ibrahim T. Aldoss, MD
City of Hope, Duarte, CA, USA

Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL, USA

Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Josep-Maria Ribera, MD, PhD
Hospital Universitari Germans Trias i Pujol, Barcelona, Spain

Gert Ossenkoppele, MD, PhD
VU University Medical Center, Amsterdam, the Netherlands


Download the meeting agenda

View Agenda


  • New Developments in First-line Treatment of MDS
  • New Developments in Targeted Treatment of MDS and Treatment of Relapsed/Refractory (R/R) MDS
  • Advances in Acute Myeloid Leukemia (AML): Newly Diagnosed
  • Advances in AML: Newly Diagnosed Elderly and/or Unfit and R/R Disease
  • Advances in Acute Lymphoblastic Leukemia (ALL): Newly Diagnosed
  • Advances in ALL: R/R Disease

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.